BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 7607341)

  • 21. Advanced glycation end products in human senile and diabetic cataractous lenses.
    Zarina S; Zhao HR; Abraham EC
    Mol Cell Biochem; 2000 Jul; 210(1-2):29-34. PubMed ID: 10976755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycation as the glucose link to diabetic complications.
    Gugliucci A
    J Am Osteopath Assoc; 2000 Oct; 100(10):621-34. PubMed ID: 11105451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ABC of the diabetic hand--advanced glycosylation end products, browning and collagen.
    Isdale AH
    Br J Rheumatol; 1993 Oct; 32(10):859-61. PubMed ID: 8401994
    [No Abstract]   [Full Text] [Related]  

  • 24. The Maillard reaction in the human body. The main discoveries and factors that affect glycation.
    Tessier FJ
    Pathol Biol (Paris); 2010 Jun; 58(3):214-9. PubMed ID: 19896783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relevance of the early and advanced Maillard reaction in diabetic neuropathy.
    Monnier VM; Miyata S; Nagaraj RH; Sell DR
    Diabet Med; 1993; 10 Suppl 2():103S-106S. PubMed ID: 7687529
    [No Abstract]   [Full Text] [Related]  

  • 26. New biomarkers of Maillard reaction damage to proteins.
    Wells-Knecht KJ; Brinkmann E; Wells-Knecht MC; Litchfield JE; Ahmed MU; Reddy S; Zyzak DV; Thorpe SR; Baynes JW
    Nephrol Dial Transplant; 1996; 11 Suppl 5():41-7. PubMed ID: 9044306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonenzymatic glycation of collagen in aging and diabetes.
    Reiser KM
    Proc Soc Exp Biol Med; 1991 Jan; 196(1):17-29. PubMed ID: 1984239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Role of Maillard products in the chronic complications of diabetes mellitus. Bioclinical applications].
    Trivin F
    Ann Pharm Fr; 1998; 56(5):193-6. PubMed ID: 9805817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Non-enzymatic glycosylation of proteins. Implications in the pathogenesis and metabolic control of diabetes mellitus].
    Martins e Silva J
    Acta Med Port; 1983; 4(9-10):421-30. PubMed ID: 6362337
    [No Abstract]   [Full Text] [Related]  

  • 30. Bimolecular interaction of argpyrimidine (a Maillard reaction product) in in vitro non-enzymatic protein glycation model and its potential role as an antiglycating agent.
    Bhattacherjee A; Dhara K; Chakraborti AS
    Int J Biol Macromol; 2017 Sep; 102():1274-1285. PubMed ID: 28487198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accumulation of Maillard reaction products in skin collagen in diabetes and aging.
    Dyer DG; Dunn JA; Thorpe SR; Lyons TJ; McCance DR; Baynes JW
    Ann N Y Acad Sci; 1992 Nov; 663():421-2. PubMed ID: 1482072
    [No Abstract]   [Full Text] [Related]  

  • 32. [Non-enzymatic glycosylation of proteins].
    Sawicki G
    Postepy Hig Med Dosw; 1983; 37(2):195-213. PubMed ID: 6364080
    [No Abstract]   [Full Text] [Related]  

  • 33. Protein modification by the degradation products of ascorbate: formation of a novel pyrrole from the Maillard reaction of L-threose with proteins.
    Nagaraj RH; Monnier VM
    Biochim Biophys Acta; 1995 Nov; 1253(1):75-84. PubMed ID: 7492603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reference values for the Chinese population of skin autofluorescence as a marker of advanced glycation end products accumulated in tissue.
    Yue X; Hu H; Koetsier M; Graaff R; Han C
    Diabet Med; 2011 Jul; 28(7):818-23. PubMed ID: 21204956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes mellitus and Alzheimer's disease: glycation as a biochemical link.
    Smith MA; Sayre LM; Perry G
    Diabetologia; 1996 Feb; 39(2):247. PubMed ID: 8635681
    [No Abstract]   [Full Text] [Related]  

  • 36. The Development of Maillard Reaction, and Advanced Glycation End Product (AGE)-Receptor for AGE (RAGE) Signaling Inhibitors as Novel Therapeutic Strategies for Patients with AGE-Related Diseases.
    Shen CY; Lu CH; Wu CH; Li KJ; Kuo YM; Hsieh SC; Yu CL
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33261212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is glucose the sole source of tissue browning in diabetes mellitus?
    Hunt JV; Wolff SP
    FEBS Lett; 1990 Aug; 269(1):258-60. PubMed ID: 2117556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of natural antioxidants regulating advanced glycosylation end products of Maillard reaction.
    Jia W; Guo A; Zhang R; Shi L
    Food Chem; 2023 Mar; 404(Pt A):134541. PubMed ID: 36240555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The significance of the products of the Maillard (browning) reaction in diabetes.
    Dominiczak MH
    Diabet Med; 1991 Jul; 8(6):505-16. PubMed ID: 1832349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired immunoglobulin G Fc fragment function in diabetics is caused by a mechanism different from glycation.
    Dolhofer-Bliesener R; Lechner B; Gerbitz KD
    Eur J Clin Chem Clin Biochem; 1994 May; 32(5):329-36. PubMed ID: 8086514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.